Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Sander

Showing results (81-90 of 206) with videos related to

Pageof 21
Sort By:
Bulletin of the World Health Organization|May 19, 2001
The treatment of epilepsy in developing countries: where do we go from here?R A Scott, S D Lhatoo, J W Sander
Arquivos De Neuro-Psiquiatria|December 1, 1995
Myoclonic epilepsy of late onset in trisomy 21L M Li, M F O'Donoghue, J W Sander
Lancet (London, England)|September 4, 1993
Acute encephalopathy with vigabatrinM K Sharief, J W Sander, S D Shorvon
Lancet (London, England)|July 11, 1998
Hippocampal damage caused by seizures in temporal lobe epilepsyS M Sisodiya, S L Free, J W Sander
Epilepsia|March 10, 2001
Adverse event monitoring in lamotrigine patients: a pharmacoepidemiologic study in the United KingdomI C Wong, G E Mawer, J W Sander
Journal of Neurology, Neurosurgery, and Psychiatry|October 19, 2001
The dynamics of drug treatment in epilepsy: an observational study in an unselected population based cohort with newly diagnosed epilepsy followed up prospectively over 11-14 yearsS D Lhatoo, J W Sander, S D Shorvon
BMJ (Clinical Research Ed.)|November 9, 1996
Long-term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcomeM C Walker, L M Li, J W Sander
Epilepsy Research|May 1, 1993
The effect of oral flumazenil on interictal epileptic activity: results of a double-blind, placebo-controlled studyM K Sharief, J W Sander, S D Shorvon
Epilepsia|December 13, 2000
Idiopathic generalized epilepsy presenting with hemiconvulsive seizuresM A Kiley, S J Smith, J W Sander
Lancet (London, England)|November 4, 1995
Remission of epilepsy. The NGPS. National General Practice Study of EpilepsyO C Cockerell, J W Sander, S D Shorvon
Pageof 21

Showing results (81-90 of 206) with videos related to

Sort By:
Pageof 21
Bulletin of the World Health Organization|May 19, 2001
The treatment of epilepsy in developing countries: where do we go from here?R A Scott, S D Lhatoo, J W Sander
Arquivos De Neuro-Psiquiatria|December 1, 1995
Myoclonic epilepsy of late onset in trisomy 21L M Li, M F O'Donoghue, J W Sander
Lancet (London, England)|September 4, 1993
Acute encephalopathy with vigabatrinM K Sharief, J W Sander, S D Shorvon
Lancet (London, England)|July 11, 1998
Hippocampal damage caused by seizures in temporal lobe epilepsyS M Sisodiya, S L Free, J W Sander
Epilepsia|March 10, 2001
Adverse event monitoring in lamotrigine patients: a pharmacoepidemiologic study in the United KingdomI C Wong, G E Mawer, J W Sander
Journal of Neurology, Neurosurgery, and Psychiatry|October 19, 2001
The dynamics of drug treatment in epilepsy: an observational study in an unselected population based cohort with newly diagnosed epilepsy followed up prospectively over 11-14 yearsS D Lhatoo, J W Sander, S D Shorvon
BMJ (Clinical Research Ed.)|November 9, 1996
Long-term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcomeM C Walker, L M Li, J W Sander
Epilepsy Research|May 1, 1993
The effect of oral flumazenil on interictal epileptic activity: results of a double-blind, placebo-controlled studyM K Sharief, J W Sander, S D Shorvon
Epilepsia|December 13, 2000
Idiopathic generalized epilepsy presenting with hemiconvulsive seizuresM A Kiley, S J Smith, J W Sander
Lancet (London, England)|November 4, 1995
Remission of epilepsy. The NGPS. National General Practice Study of EpilepsyO C Cockerell, J W Sander, S D Shorvon
Pageof 21